With the rise of GLP-1 therapies, we are now seeing a new pattern in the treatment room: sudden loss of facial volume, accelerated skin laxity, early fine lines and crepey texture, and changes that are structural, not inflammatory.
This isn't simply "cosmetic aging." It's a physiologic consequence of rapid fat loss, muscle changes, and altered cellular metabolism.
What Are GLP-1 Medications and Why Are They Causing Skin Concerns?
GLP-1 receptor agonists like semaglutide and tirzepatide mimic a hormone that slows digestion and promotes satiety, helping with weight loss. But rapid fat reduction can lead to loss of volume, skin laxity or sagging, and visible changes in muscle tone — sometimes referred to as "Ozempic face." Muscle mass loss combined with collagen decline can accelerate visible signs of aging.
The Role of NAD+ in Skin and Muscle Health
NAD+ (nicotinamide adenine dinucleotide) is a critical coenzyme involved in cellular energy, mitochondrial function, and DNA repair. As we age, NAD+ levels naturally decline, and this drop is further accelerated by metabolic stress, inflammation, and muscle loss.
Pro NAD supports NAD+ production and energy metabolism, helping skin cells maintain optimal performance during times of stress or change:
- Supports collagen and elastin synthesis to address visible laxity
- Energizes fibroblasts for stronger structural integrity
- Helps buffer oxidative stress and inflammation
- May support muscle cell recovery and improve skin tone and density
As the industry moves toward longevity and metabolic health, our approach to skincare must evolve too. We carry supporting products like the Dynamic Skin Sculptor to meet the moment with science-backed, cell-supporting strategies.
